Ardevora Asset Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,410,876
Closed -$21.9M 119
2020
Q3
$21.9M Sell
1,410,876
-1,069,600
-43% -$18.4M 0.4% 112
2020
Q2
$45.4M Buy
2,480,476
+332,014
+15% +$5.85M 0.89% 66
2020
Q1
$33.3M Buy
2,148,462
+8,442
+0.4% +$204K 0.88% 81
2019
Q4
$64M Buy
2,140,020
+223,700
+12% +$5.82M 1.44% 3
2019
Q3
$41.9M Buy
1,916,320
+127,800
+7% +$2.92M 1.17% 35
2019
Q2
$45.1M Buy
1,788,520
+343,900
+24% +$8.16M 1.1% 7
2019
Q1
$35.7M Sell
1,444,620
-193,500
-12% -$4.62M 0.93% 53
2018
Q4
$30.3M Buy
1,638,120
+1,556,002
+1,895% +$37M 0.91% 67
2018
Q3
$2.11M Buy
+82,118
New +$1.88M 0.06% 117

Other funds holding BHC

Ardevora Asset Management's BHC Position: Q4 2020 in Review

Ardevora Asset Management sold out of Bausch Health (BHC) in Q4 2020, closing a stake of 1,410,876 shares — an estimated $21.9M sold.

Ardevora Asset Management first reported a position in BHC in Q3 2018 and held it in 9 quarters. The position peaked at $64M in Q4 2019. 338 funds tracked by Wall St. Rank hold BHC as of Q4 2020.

  • Ardevora Asset Management reported no remaining Bausch Health position as of Q4 2020 after selling out during the quarter.
  • Ardevora Asset Management sold 1,410,876 Bausch Health shares in Q4 2020, an estimated $21.9M.
  • Ardevora Asset Management first reported a position in Bausch Health in Q3 2018 and held it in 9 quarters.
  • Ardevora Asset Management's Bausch Health position peaked at $64M in Q4 2019.
  • 338 funds tracked by Wall St. Rank held Bausch Health as of Q4 2020.

Based on Ardevora Asset Management's 13F filing for Q4 2020, filed 14 Jan 2021.